Susquehanna initiated coverage of Kyndryl with a rating of Neutral and set a new price target of $14.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/22/2024 | $33.00 → $37.00 | Outperform | Oppenheimer |
| 11/22/2024 | $40.00 | Buy | BofA Securities |
| 6/27/2024 | $33.00 | Outperform | Oppenheimer |
| 2/12/2024 | $19.00 → $27.00 | Neutral → Positive | Susquehanna |
| 1/8/2024 | $26.00 | In-line → Outperform | Evercore ISI |
| 12/18/2023 | $20.00 → $25.00 | Neutral → Overweight | JP Morgan |
| 4/21/2023 | $22.00 | Sector Outperform | Scotiabank |
| 1/12/2023 | $14.00 | Neutral | Susquehanna |